Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Anne Fuhlbrigge

Concepts (429)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Asthma
96
2024
2225
8.870
 Why?
Adrenal Cortex Hormones
27
2024
535
3.220
 Why?
Anti-Asthmatic Agents
27
2024
374
3.070
 Why?
Forced Expiratory Volume
19
2019
508
1.600
 Why?
Pulmonary Disease, Chronic Obstructive
11
2022
998
1.410
 Why?
Severity of Illness Index
20
2020
2734
1.020
 Why?
Administration, Inhalation
24
2024
673
0.920
 Why?
Anti-Inflammatory Agents
10
2016
481
0.900
 Why?
Lung Transplantation
10
2017
290
0.880
 Why?
Albuterol
5
2015
105
0.860
 Why?
Bronchodilator Agents
12
2016
245
0.840
 Why?
Budesonide
14
2016
89
0.810
 Why?
Nedocromil
11
2016
32
0.740
 Why?
Self Report
3
2023
800
0.720
 Why?
Humans
126
2025
129527
0.720
 Why?
Nasal Polyps
1
2021
59
0.720
 Why?
Endpoint Determination
2
2020
76
0.700
 Why?
Pharmacogenetics
2
2015
172
0.690
 Why?
Food Hypersensitivity
1
2022
177
0.640
 Why?
Sinusitis
1
2021
211
0.620
 Why?
Lung
7
2019
3928
0.610
 Why?
Virus Diseases
1
2021
210
0.600
 Why?
Physicians
2
2021
872
0.590
 Why?
Hospitalization
13
2020
2076
0.590
 Why?
Glucocorticoids
4
2022
583
0.590
 Why?
Remote Consultation
3
2025
46
0.580
 Why?
Symptom Assessment
1
2019
125
0.570
 Why?
Sleep Apnea, Obstructive
1
2021
278
0.550
 Why?
Oxygen Inhalation Therapy
4
2020
145
0.530
 Why?
Child
53
2022
20932
0.530
 Why?
Androstadienes
3
2012
106
0.520
 Why?
Bone Density
2
2014
463
0.520
 Why?
Emergency Service, Hospital
9
2013
1918
0.520
 Why?
Disease Progression
14
2020
2628
0.520
 Why?
Male
81
2024
63586
0.510
 Why?
Managed Care Programs
8
2008
128
0.510
 Why?
Precision Medicine
1
2020
385
0.500
 Why?
Adult
46
2024
35505
0.500
 Why?
Female
80
2024
68650
0.480
 Why?
Patient Reported Outcome Measures
1
2018
374
0.470
 Why?
Practice Patterns, Physicians'
7
2020
1257
0.460
 Why?
Cost Savings
1
2015
78
0.460
 Why?
Adrenergic beta-2 Receptor Agonists
4
2020
36
0.460
 Why?
Middle Aged
39
2024
31087
0.420
 Why?
Cost-Benefit Analysis
7
2022
566
0.420
 Why?
Peak Expiratory Flow Rate
2
2011
36
0.420
 Why?
Comorbidity
4
2021
1548
0.380
 Why?
Adolescent
37
2019
20409
0.360
 Why?
Surveys and Questionnaires
14
2022
5429
0.360
 Why?
Quality of Life
12
2023
2694
0.350
 Why?
Administration, Oral
6
2021
783
0.350
 Why?
Mentors
1
2012
175
0.350
 Why?
Medical Records Systems, Computerized
3
2008
93
0.340
 Why?
United States
23
2022
13865
0.340
 Why?
Respiratory Function Tests
10
2015
581
0.330
 Why?
Child, Preschool
31
2016
10499
0.330
 Why?
Medication Adherence
3
2023
560
0.330
 Why?
Faculty, Medical
1
2012
268
0.320
 Why?
Interprofessional Relations
3
2021
277
0.320
 Why?
Child Development
1
2014
458
0.320
 Why?
Spirometry
8
2020
257
0.310
 Why?
Treatment Outcome
15
2017
10232
0.310
 Why?
Aged
22
2022
22063
0.300
 Why?
Oxygen
3
2018
914
0.300
 Why?
Group Practice
1
2008
7
0.300
 Why?
Anti-Allergic Agents
2
2008
45
0.290
 Why?
Computer Simulation
1
2012
937
0.290
 Why?
Phenotype
5
2021
3058
0.280
 Why?
Dyspnea
3
2022
238
0.270
 Why?
Drug Utilization
4
2005
170
0.260
 Why?
Primary Health Care
5
2025
1677
0.260
 Why?
Follow-Up Studies
17
2017
4891
0.260
 Why?
Primary Graft Dysfunction
2
2017
29
0.250
 Why?
Quality Assurance, Health Care
1
2008
316
0.250
 Why?
Bronchiolitis Obliterans
3
2017
68
0.240
 Why?
Randomized Controlled Trials as Topic
7
2020
1368
0.240
 Why?
Gift Giving
1
2005
11
0.240
 Why?
Diagnostic Techniques, Respiratory System
1
2005
5
0.240
 Why?
Allergists
2
2022
12
0.240
 Why?
Respiratory Sounds
1
2006
118
0.240
 Why?
Genetic Testing
1
2008
422
0.240
 Why?
Delivery of Health Care
2
2021
896
0.230
 Why?
Cohort Studies
14
2013
5423
0.220
 Why?
Time Factors
10
2020
6530
0.220
 Why?
Antibodies, Monoclonal
2
2008
1366
0.220
 Why?
Leadership
2
2022
358
0.220
 Why?
Specialization
2
2025
143
0.220
 Why?
Natural Language Processing
1
2025
94
0.220
 Why?
Retrospective Studies
17
2022
14532
0.220
 Why?
Massachusetts
5
2016
158
0.210
 Why?
Medicine
1
2025
117
0.210
 Why?
Genetic Variation
1
2008
936
0.210
 Why?
Recurrence
5
2013
1011
0.200
 Why?
Rhinitis, Allergic, Perennial
1
2003
23
0.200
 Why?
Health Status
1
2008
756
0.200
 Why?
Steroids
8
2011
158
0.200
 Why?
Young Adult
11
2019
12438
0.200
 Why?
Predictive Value of Tests
9
2012
1950
0.200
 Why?
Multicenter Studies as Topic
4
2018
287
0.200
 Why?
Prevalence
4
2022
2561
0.190
 Why?
Beclomethasone
1
2022
27
0.190
 Why?
Models, Theoretical
4
2007
548
0.190
 Why?
Desensitization, Immunologic
1
2022
90
0.180
 Why?
Academic Medical Centers
2
2022
478
0.180
 Why?
Biomarkers
3
2021
3968
0.180
 Why?
Tiotropium Bromide
2
2018
19
0.180
 Why?
Nebulizers and Vaporizers
2
2020
84
0.180
 Why?
Patient Preference
1
2023
183
0.180
 Why?
Social Class
2
2022
258
0.180
 Why?
Electronic Health Records
2
2025
977
0.170
 Why?
Churg-Strauss Syndrome
1
2020
25
0.170
 Why?
Bronchoconstriction
3
2011
31
0.170
 Why?
Pulmonologists
1
2020
15
0.170
 Why?
Granulomatosis with Polyangiitis
1
2020
43
0.170
 Why?
Capacity Building
1
2021
59
0.170
 Why?
Muscarinic Antagonists
1
2020
27
0.170
 Why?
Agammaglobulinemia
1
2020
33
0.170
 Why?
Physician-Patient Relations
2
2021
539
0.170
 Why?
Risk Factors
12
2018
9779
0.160
 Why?
Practice Guidelines as Topic
5
2020
1510
0.160
 Why?
Air Pollution, Indoor
2
2002
141
0.160
 Why?
Treatment Adherence and Compliance
1
2019
24
0.150
 Why?
Exercise Test
1
2022
608
0.150
 Why?
Receptors, IgE
2
2009
44
0.150
 Why?
Prognosis
8
2017
3772
0.150
 Why?
Allergens
1
2021
385
0.140
 Why?
Emergency Medical Services
2
2007
521
0.140
 Why?
Vitamin D
2
2012
379
0.140
 Why?
Fossil Fuels
1
1997
8
0.140
 Why?
Drug Prescriptions
2
2011
242
0.140
 Why?
Hypersensitivity
1
2020
249
0.140
 Why?
Alemtuzumab
1
2017
15
0.140
 Why?
Photopheresis
1
2017
9
0.140
 Why?
Biological Products
1
2020
207
0.140
 Why?
Respiration
1
2017
193
0.130
 Why?
Aged, 80 and over
6
2019
7052
0.130
 Why?
Respiration Disorders
1
1997
71
0.130
 Why?
Physicians, Primary Care
3
2021
230
0.130
 Why?
Drug Combinations
3
2012
329
0.130
 Why?
Socioeconomic Factors
4
2022
1211
0.130
 Why?
Immunomodulation
1
2017
92
0.130
 Why?
Statistics, Nonparametric
1
2017
422
0.130
 Why?
Drug Therapy, Combination
5
2020
1037
0.130
 Why?
Patient Admission
1
2018
183
0.130
 Why?
Breath Tests
2
2008
87
0.120
 Why?
Scopolamine Derivatives
1
2015
7
0.120
 Why?
Immunoglobulin G
1
2020
851
0.120
 Why?
Embolism, Fat
1
2015
11
0.120
 Why?
Tobacco Smoke Pollution
2
2010
231
0.120
 Why?
Transplants
1
2015
35
0.120
 Why?
Cholinergic Antagonists
1
2015
29
0.120
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2015
103
0.120
 Why?
Fluticasone-Salmeterol Drug Combination
2
2012
12
0.120
 Why?
Genomics
2
2018
715
0.120
 Why?
Referral and Consultation
1
2021
732
0.120
 Why?
Postoperative Complications
2
2017
2475
0.120
 Why?
Carcinoma, Bronchogenic
1
2015
19
0.120
 Why?
Longitudinal Studies
6
2017
2724
0.120
 Why?
Overweight
2
2011
531
0.110
 Why?
Telemedicine
1
2023
792
0.110
 Why?
Respiratory Tract Infections
2
2012
376
0.110
 Why?
Ambulatory Care Information Systems
2
2005
5
0.110
 Why?
Graft Rejection
2
2013
598
0.110
 Why?
Guideline Adherence
3
2020
526
0.110
 Why?
Prednisolone
1
2014
82
0.110
 Why?
Environmental Exposure
3
2006
463
0.110
 Why?
Risk
4
2015
857
0.110
 Why?
Education, Medical, Continuing
2
2005
121
0.110
 Why?
Quality Improvement
1
2022
1103
0.110
 Why?
Airway Obstruction
1
2015
154
0.110
 Why?
Forecasting
1
2015
360
0.100
 Why?
Transplantation
1
2013
31
0.100
 Why?
Bronchial Hyperreactivity
3
2010
109
0.100
 Why?
Office Visits
4
2011
86
0.100
 Why?
Medicare
2
2022
716
0.100
 Why?
Insurance Claim Review
1
2013
62
0.100
 Why?
Peer Group
2
2012
226
0.100
 Why?
Double-Blind Method
5
2010
1873
0.100
 Why?
Antibodies, Monoclonal, Humanized
2
2008
755
0.100
 Why?
Research
1
2015
419
0.100
 Why?
Cost of Illness
3
2003
276
0.100
 Why?
Growth
1
2012
60
0.100
 Why?
Costs and Cost Analysis
1
2013
201
0.100
 Why?
Methacholine Chloride
3
2008
52
0.100
 Why?
Cytomegalovirus Infections
2
2012
190
0.100
 Why?
Feedback
1
2012
162
0.100
 Why?
Metered Dose Inhalers
1
2012
16
0.100
 Why?
Drug Dosage Calculations
1
2011
22
0.090
 Why?
Mycoses
1
2012
73
0.090
 Why?
Logistic Models
5
2017
1983
0.090
 Why?
Antifungal Agents
1
2012
130
0.090
 Why?
Body Height
1
2012
194
0.090
 Why?
Effect Modifier, Epidemiologic
1
2011
12
0.090
 Why?
Multivariate Analysis
7
2017
1491
0.090
 Why?
Professional Role
1
2012
157
0.090
 Why?
Morbidity
2
2022
300
0.090
 Why?
Medication Errors
1
2012
96
0.090
 Why?
Obesity
3
2015
2875
0.090
 Why?
Epidemiologic Studies
1
2011
64
0.090
 Why?
Mycobacterium
1
2012
106
0.090
 Why?
Diagnostic Errors
1
2012
162
0.090
 Why?
Patient Readmission
1
2016
667
0.090
 Why?
Secondary Prevention
1
2012
220
0.090
 Why?
Pneumococcal Vaccines
1
2012
141
0.090
 Why?
Lung Diseases
1
2017
741
0.080
 Why?
Drug Resistance
1
2011
163
0.080
 Why?
Program Development
1
2012
354
0.080
 Why?
Vitamin D Deficiency
1
2012
177
0.080
 Why?
Probability
1
2011
302
0.080
 Why?
Ambulatory Care
2
2011
507
0.080
 Why?
Chi-Square Distribution
2
2017
515
0.080
 Why?
Decision Support Techniques
2
2012
401
0.080
 Why?
Bronchial Provocation Tests
2
2008
51
0.080
 Why?
Incidence
5
2020
2643
0.080
 Why?
Fluticasone
2
2008
90
0.080
 Why?
Algorithms
1
2017
1614
0.080
 Why?
Immunoglobulin E
2
2008
330
0.080
 Why?
Vital Capacity
4
2017
290
0.080
 Why?
Receptors, Corticotropin-Releasing Hormone
1
2009
27
0.080
 Why?
Proportional Hazards Models
1
2012
1196
0.080
 Why?
Lectins, C-Type
1
2009
71
0.080
 Why?
Cross-Sectional Studies
6
2010
5078
0.080
 Why?
Health Knowledge, Attitudes, Practice
2
2012
1283
0.080
 Why?
Health Services
2
2007
99
0.080
 Why?
Surgical Wound Infection
1
2012
282
0.080
 Why?
Pandemics
3
2022
1500
0.080
 Why?
Smoking
3
2017
1501
0.080
 Why?
Odds Ratio
4
2017
1018
0.080
 Why?
Medication Therapy Management
1
2010
71
0.080
 Why?
Kaplan-Meier Estimate
3
2016
850
0.080
 Why?
Acute Disease
1
2011
975
0.080
 Why?
Vitamin K Epoxide Reductases
1
2008
12
0.070
 Why?
Cytochrome P-450 CYP2C9
1
2008
20
0.070
 Why?
Eosinophil Cationic Protein
1
2008
10
0.070
 Why?
Mixed Function Oxygenases
1
2008
41
0.070
 Why?
Program Evaluation
1
2012
873
0.070
 Why?
Genetic Predisposition to Disease
1
2016
2271
0.070
 Why?
Aryl Hydrocarbon Hydroxylases
1
2008
48
0.070
 Why?
Genetic Techniques
1
2008
62
0.070
 Why?
Quality-Adjusted Life Years
2
2006
106
0.070
 Why?
Markov Chains
2
2006
117
0.070
 Why?
Trastuzumab
1
2008
100
0.070
 Why?
Insurance, Pharmaceutical Services
1
2008
22
0.070
 Why?
Cost Sharing
1
2008
14
0.070
 Why?
Interviews as Topic
1
2011
707
0.070
 Why?
State Health Plans
1
2008
29
0.070
 Why?
Adrenergic beta-Agonists
1
2008
133
0.070
 Why?
Smoking Cessation
1
2012
409
0.070
 Why?
Reimbursement Mechanisms
1
2008
84
0.070
 Why?
Chronic Disease
3
2017
1722
0.070
 Why?
Health Services Accessibility
2
2021
897
0.070
 Why?
Antibodies, Anti-Idiotypic
1
2007
58
0.070
 Why?
Warfarin
1
2008
147
0.070
 Why?
Exercise Tolerance
2
2022
272
0.070
 Why?
Mycobacterium Infections, Nontuberculous
1
2012
353
0.070
 Why?
Tomography, X-Ray Computed
1
2017
2503
0.070
 Why?
Omalizumab
1
2007
50
0.070
 Why?
Factor Analysis, Statistical
1
2008
282
0.070
 Why?
Databases, Factual
1
2012
1261
0.070
 Why?
Health Surveys
2
2006
493
0.070
 Why?
Antiviral Agents
1
2012
719
0.070
 Why?
Influenza Vaccines
1
2012
533
0.070
 Why?
Lung Diseases, Interstitial
1
2013
611
0.070
 Why?
Animals, Domestic
1
2006
14
0.070
 Why?
Receptor, ErbB-2
1
2008
325
0.060
 Why?
Biomedical Research
1
2012
639
0.060
 Why?
Eosinophils
1
2008
324
0.060
 Why?
Physicians, Family
2
2004
205
0.060
 Why?
Models, Biological
1
2012
1717
0.060
 Why?
Health Benefit Plans, Employee
1
2005
22
0.060
 Why?
Health Policy
1
2008
350
0.060
 Why?
Database Management Systems
1
2005
48
0.060
 Why?
Patients
1
2006
169
0.060
 Why?
Infant
3
2008
9005
0.060
 Why?
Hip Fractures
1
2006
83
0.060
 Why?
Insurance Coverage
1
2006
219
0.060
 Why?
Clinical Competence
1
2012
1015
0.060
 Why?
Body Mass Index
3
2015
2269
0.060
 Why?
Patient Education as Topic
3
2005
738
0.060
 Why?
Utilization Review
1
2004
36
0.060
 Why?
Mass Screening
1
2012
1186
0.050
 Why?
Gene Expression Profiling
1
2011
1684
0.050
 Why?
Prenatal Exposure Delayed Effects
1
2010
572
0.050
 Why?
Medicaid
1
2008
418
0.050
 Why?
Anticoagulants
1
2008
637
0.050
 Why?
Vaccination
1
2012
1348
0.050
 Why?
Sex Factors
3
2016
1966
0.050
 Why?
Anti-Bacterial Agents
2
2004
1708
0.050
 Why?
Attitude to Health
1
2006
432
0.050
 Why?
Nitric Oxide
1
2008
897
0.050
 Why?
Circadian Rhythm
1
2006
416
0.050
 Why?
Clinical Trials as Topic
2
2005
1001
0.050
 Why?
Parents
3
2006
1309
0.050
 Why?
Case Management
1
2003
63
0.050
 Why?
Choice Behavior
1
2004
165
0.050
 Why?
Puerto Rico
1
2022
52
0.050
 Why?
Symptom Flare Up
1
2022
38
0.050
 Why?
Lung Neoplasms
1
2015
2342
0.050
 Why?
Sputum
1
2004
302
0.050
 Why?
Academies and Institutes
1
2022
50
0.050
 Why?
Health Services Research
1
2004
389
0.050
 Why?
Minority Groups
1
2003
250
0.050
 Why?
Survival Rate
2
2016
1870
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
72
0.040
 Why?
Electronics
1
2021
74
0.040
 Why?
Clinical Trials, Phase III as Topic
1
2020
94
0.040
 Why?
Sample Size
1
2020
116
0.040
 Why?
Efficiency
1
2021
92
0.040
 Why?
Health Care Reform
1
2021
100
0.040
 Why?
Schools, Medical
1
2021
136
0.040
 Why?
Risk Assessment
3
2020
3255
0.040
 Why?
Patient Selection
2
2020
659
0.040
 Why?
Pragmatic Clinical Trials as Topic
1
2020
62
0.040
 Why?
Patient Compliance
2
2016
567
0.040
 Why?
Language
1
2022
283
0.040
 Why?
Stress, Psychological
1
2007
1067
0.040
 Why?
Time
1
2019
77
0.040
 Why?
Cluster Analysis
2
2014
483
0.040
 Why?
Health Education
1
2002
334
0.040
 Why?
Quality of Health Care
1
2003
607
0.040
 Why?
Republic of Korea
1
2017
29
0.040
 Why?
Poland
1
2017
31
0.040
 Why?
Bronchitis, Chronic
1
2017
19
0.040
 Why?
Cooperative Behavior
1
2021
432
0.040
 Why?
Sensitivity and Specificity
3
2013
1842
0.040
 Why?
Patient-Centered Care
1
2003
501
0.040
 Why?
Nitrogen Dioxide
1
1997
32
0.030
 Why?
Long-Term Care
1
2018
92
0.030
 Why?
Geography
1
2018
189
0.030
 Why?
Antineoplastic Agents
1
2008
2044
0.030
 Why?
Self Concept
1
2019
240
0.030
 Why?
Monitoring, Physiologic
2
2012
261
0.030
 Why?
Aftercare
1
2019
206
0.030
 Why?
Pediatrics
1
2005
1068
0.030
 Why?
Netherlands
1
2016
77
0.030
 Why?
Tuberculosis, Pulmonary
1
2017
135
0.030
 Why?
Perception
1
2019
346
0.030
 Why?
Feasibility Studies
1
2020
869
0.030
 Why?
Formoterol Fumarate
1
2015
7
0.030
 Why?
Forced Expiratory Flow Rates
1
2015
13
0.030
 Why?
Ethanolamines
1
2015
17
0.030
 Why?
Salmeterol Xinafoate
1
2015
41
0.030
 Why?
Receptors, Adrenergic, beta-2
1
2015
46
0.030
 Why?
Treatment Failure
1
2016
339
0.030
 Why?
Dose-Response Relationship, Drug
2
2011
2013
0.030
 Why?
Self Efficacy
1
2019
377
0.030
 Why?
Polymorphism, Single Nucleotide
2
2016
2062
0.030
 Why?
Postoperative Period
1
2016
329
0.030
 Why?
Education
1
2015
103
0.030
 Why?
Age Factors
3
2008
3150
0.030
 Why?
Fatal Outcome
1
2015
300
0.030
 Why?
Immunosuppressive Agents
2
2015
858
0.030
 Why?
Pilot Projects
1
2020
1594
0.030
 Why?
Patient Acceptance of Health Care
1
2021
761
0.030
 Why?
Biopsy
2
2013
1087
0.030
 Why?
Combined Modality Therapy
1
2017
1201
0.030
 Why?
Gene Expression
1
2018
1461
0.030
 Why?
Telephone
2
2005
167
0.030
 Why?
Echinocandins
1
2012
7
0.020
 Why?
Lipopeptides
1
2012
13
0.020
 Why?
Tissue Donors
1
2015
391
0.020
 Why?
Amphotericin B
1
2012
30
0.020
 Why?
Aspergillosis
1
2012
20
0.020
 Why?
Intention to Treat Analysis
1
2012
68
0.020
 Why?
Candidiasis
1
2012
57
0.020
 Why?
Extracorporeal Membrane Oxygenation
1
2015
285
0.020
 Why?
Transplantation, Homologous
1
2013
402
0.020
 Why?
Hypoxia
1
2019
1081
0.020
 Why?
Age Distribution
2
2003
371
0.020
 Why?
Mycobacterium avium Complex
1
2012
88
0.020
 Why?
Cromolyn Sodium
2
2001
11
0.020
 Why?
Triazoles
1
2012
148
0.020
 Why?
Leukotriene Antagonists
1
2011
43
0.020
 Why?
Self Care
2
2005
366
0.020
 Why?
Functional Residual Capacity
1
2010
8
0.020
 Why?
Colorado
1
2021
4403
0.020
 Why?
Reference Values
1
2012
795
0.020
 Why?
Costa Rica
1
2010
16
0.020
 Why?
Principal Component Analysis
1
2011
190
0.020
 Why?
Nontuberculous Mycobacteria
1
2012
204
0.020
 Why?
Health
1
2010
75
0.020
 Why?
Genome-Wide Association Study
1
2016
1326
0.020
 Why?
Inhalation
1
2010
28
0.020
 Why?
Environment
1
2011
345
0.020
 Why?
Observation
1
2008
51
0.020
 Why?
Sex Ratio
1
2008
13
0.020
 Why?
Prospective Studies
2
2012
7150
0.020
 Why?
Least-Squares Analysis
1
2008
78
0.020
 Why?
Models, Econometric
1
2008
33
0.020
 Why?
Health Services Administration
1
2007
8
0.020
 Why?
Social Isolation
1
2007
59
0.020
 Why?
Treatment Refusal
1
2008
89
0.020
 Why?
Intelligence
1
2007
130
0.020
 Why?
Puberty
1
2008
143
0.020
 Why?
Body Weight
1
2011
941
0.020
 Why?
Child Behavior Disorders
1
2007
136
0.020
 Why?
Exercise
1
2016
1931
0.010
 Why?
Insurance, Health
1
2007
269
0.010
 Why?
CD4-Positive T-Lymphocytes
1
2011
1058
0.010
 Why?
Animals
1
2006
35334
0.010
 Why?
Genotype
1
2009
1827
0.010
 Why?
Bronchoconstrictor Agents
1
2003
16
0.010
 Why?
Health Status Indicators
1
2004
166
0.010
 Why?
Organizational Innovation
1
2004
137
0.010
 Why?
Case-Control Studies
1
2010
3383
0.010
 Why?
Systems Integration
1
2003
37
0.010
 Why?
Computer Systems
1
2003
44
0.010
 Why?
Motor Activity
1
2007
686
0.010
 Why?
Child Welfare
1
2004
209
0.010
 Why?
Histamine H1 Antagonists
1
2002
29
0.010
 Why?
Self Disclosure
1
2002
62
0.010
 Why?
Drug Administration Schedule
1
2004
763
0.010
 Why?
Administration, Intranasal
1
2002
84
0.010
 Why?
Confidence Intervals
1
2002
316
0.010
 Why?
Nurse's Role
1
2003
141
0.010
 Why?
Regression Analysis
1
2003
994
0.010
 Why?
Point-of-Care Systems
1
2003
149
0.010
 Why?
Health Care Surveys
1
2002
557
0.010
 Why?
Sex Distribution
1
2001
359
0.010
 Why?
Caregivers
1
2007
807
0.010
 Why?
Decision Support Systems, Clinical
1
2003
206
0.010
 Why?
Patient Satisfaction
1
2004
636
0.010
 Why?
Disease Management
1
2003
591
0.010
 Why?
Linear Models
1
2002
818
0.010
 Why?
Bronchoscopy
1
2000
219
0.010
 Why?
Internet
1
2003
620
0.010
 Why?
Pregnancy
1
2010
6412
0.010
 Why?
Survival Analysis
1
2000
1270
0.010
 Why?
Infant, Newborn
1
2004
5769
0.010
 Why?
Fuhlbrigge's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (429) concept(s)
_
Co-Authors Expand Description
See all (19) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)